ATHEALTERITY THERAPEUTICS LTDvs its industry peers
A metric-by-metric comparison of ALTERITY THERAPEUTICS LTD against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ATHEEsta | $800M#3 | — | — | — | — | — | — | — | — | — | -20.0%#6 | — |
| ALMS | $1.0B#2 | — | 2.2x#1 | 41.6x#1 | — | 17.3%#4 | -1886.9%#2 | -53.8%#1 | — | — | 91.0%#3 | — |
| ANL | — | — | — | — | — | 52.5%#3 | -1058.6%#1 | — | — | — | 754.2%#1 | — |
| APLM | $53M#4 | — | — | — | — | 68.8%#1 | — | — | — | — | 160.7%#2 | — |
| APLMW | $24815#6 | — | — | — | — | 68.8%#1 | — | — | — | — | — | — |
| ASND | $15.3B#1 | — | — | — | — | — | — | — | — | — | 25.7%#5 | — |
| ATAI | — | — | — | — | 1227.6%#1 | -342.2%#6 | -15751.1%#4 | -374.2%#2 | -2107.6%#1 | — | 59.4%#4 | — |
| AXIM | — | — | — | — | 434.2%#2 | -191.7%#5 | -6961.0%#3 | — | — | — | — | — |
| BCTX | $31M#5 | — | — | — | — | -449.1%#7 | — | — | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-09-16.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice